Speaker Profile

M.D., Ph.D., Founder, CEO and Chairman of the Board – Five Prime Therapeutics, Inc.

Dr. Williams founded Five Prime in 2001 and is currently its President, CEO and Chairman of the Board. Previously, Dr. Williams was head of R&D and Chief Scientific Officer of Chiron Corporation. Prior to joining Chiron, he was a professor of medicine at UCSF and served as Director of the University’s Cardiovascular Research Institution. He co-founded COR Therapeutics. Dr. Williams trained in Internal Medicine and Cardiology at the Massachusetts General Hospital where he was also Assistant Professor at the Harvard Medical School. He is a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. Dr. Williams currently serves on the board of directors of Protagonist Therapeutics, and was previously a member of the boards of directors of Chiron, COR Therapeutics, and Beckman Coulter. Dr. Williams received a B.S. from Rice University and an M.D. and a Ph.D. from Duke University.

Presentation Title and Company Description

Immunotherapy Showcase: Comprehensive Approaches to Discovery of New Tumor Microenvironment Targets
At Five Prime Therapeutics, we discover innovative immuno-oncology protein therapeutics using a unique library of essentially every extracellular protein, including many immune regulators, and advance these discoveries into clinic development. Our pipeline includes multiple clinical stage and pre-clinical immune-oncology programs.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.